U.S. inflation rises 0.1% in May from prior month, less than expected

Here are Thursday’s biggest calls on Wall Street.

The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market. 

Tom Hulick, CEO at Strategy Asset Managers, joined CNBC’s “Power Lunch” to give his opinions on a trio of stocks.